Yea Christopher Insider Trading Activity
Yea Christopher has been net-selling over the last 12 months with 0 purchases and 10 sales across 1 company.
KALV is the most-traded position with 10 trades. The largest single transaction was a sale of KALV for $475K on Jul 9, 2025.
Performance Scorecard
Forward stock performance after each transaction by Yea Christopher. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.5% | 38% | 8 |
| 90 days | — | -18.8% | 38% | 8 |
| 120 days | — | -9.4% | 17% | 6 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKALV · KalVista Pharmaceuticals, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Yea Christopher bought and sold KALV.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| May 22, 2026 | KALV | Sell | 2,358 | $26.78 | $63K | CHIEF DEVELOPMENT OFFICER |
| May 18, 2026 | KALV | Sell | 1,108 | $26.76 | $30K | CHIEF DEVELOPMENT OFFICER |
| Feb 23, 2026 | KALV | Sell | 4,347 | $15.57 | $68K | CHIEF DEVELOPMENT OFFICER |
| Feb 18, 2026 | KALV | Sell | 1,109 | $15.00 | $17K | CHIEF DEVELOPMENT OFFICER |
| Nov 24, 2025 | KALV | Sell | 4,331 | $13.45 | $58K | CHIEF DEVELOPMENT OFFICER |
| Nov 18, 2025 | KALV | Sell | 2,683 | $14.48 | $39K | CHIEF DEVELOPMENT OFFICER |
| Aug 25, 2025 | KALV | Sell | 1,954 | $13.42 | $26K | CHIEF DEVELOPMENT OFFICER |
| Aug 22, 2025 | KALV | Sell | 2,362 | $13.22 | $31K | CHIEF DEVELOPMENT OFFICER |
| Aug 18, 2025 | KALV | Sell | 2,649 | $13.19 | $35K | CHIEF DEVELOPMENT OFFICER |
| Jul 9, 2025 | KALV | Sell | 30,250 | $15.69 | $475K | CHIEF DEVELOPMENT OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 10 | $841K |
Other insiders at KalVista Pharmaceuticals, Inc.
5 other tracked filers at KALV.